Impax Asset Management Group plc Has $199.98 Million Stake in Chemed Co. (NYSE:CHE)

Impax Asset Management Group plc increased its position in shares of Chemed Co. (NYSE:CHE) by 4.7% in the 3rd quarter, HoldingsChannel.com reports. The firm owned 332,757 shares of the company’s stock after purchasing an additional 14,814 shares during the quarter. Impax Asset Management Group plc’s holdings in Chemed were worth $199,977,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds have also added to or reduced their stakes in CHE. EntryPoint Capital LLC raised its position in shares of Chemed by 14.0% in the first quarter. EntryPoint Capital LLC now owns 147 shares of the company’s stock valued at $94,000 after buying an additional 18 shares in the last quarter. Covestor Ltd lifted its position in shares of Chemed by 10.6% during the 1st quarter. Covestor Ltd now owns 219 shares of the company’s stock worth $141,000 after buying an additional 21 shares during the last quarter. GAMMA Investing LLC lifted its holdings in shares of Chemed by 34.4% in the second quarter. GAMMA Investing LLC now owns 86 shares of the company’s stock worth $47,000 after acquiring an additional 22 shares during the last quarter. Ballentine Partners LLC grew its holdings in shares of Chemed by 4.1% during the 3rd quarter. Ballentine Partners LLC now owns 655 shares of the company’s stock valued at $394,000 after purchasing an additional 26 shares during the last quarter. Finally, Everpar Advisors LLC grew its holdings in shares of Chemed by 4.9% during the 2nd quarter. Everpar Advisors LLC now owns 580 shares of the company’s stock valued at $315,000 after purchasing an additional 27 shares during the last quarter. 95.85% of the stock is owned by institutional investors and hedge funds.

Chemed Trading Down 1.3 %

Shares of Chemed stock opened at $525.03 on Tuesday. The firm has a market capitalization of $7.90 billion, a PE ratio of 26.53, a price-to-earnings-growth ratio of 2.19 and a beta of 0.46. The firm’s 50 day moving average is $584.37 and its 200 day moving average is $567.22. Chemed Co. has a 1 year low of $523.33 and a 1 year high of $654.62.

Chemed (NYSE:CHE) last posted its earnings results on Tuesday, October 29th. The company reported $5.64 earnings per share for the quarter, missing analysts’ consensus estimates of $5.76 by ($0.12). Chemed had a return on equity of 27.86% and a net margin of 12.69%. The business had revenue of $606.18 million for the quarter, compared to the consensus estimate of $612.22 million. During the same period in the previous year, the firm earned $5.32 earnings per share. The company’s revenue was up 7.4% compared to the same quarter last year. As a group, research analysts anticipate that Chemed Co. will post 22.41 earnings per share for the current year.

Insiders Place Their Bets

In other news, Director George J. Walsh III sold 400 shares of the business’s stock in a transaction dated Thursday, September 26th. The stock was sold at an average price of $597.47, for a total value of $238,988.00. Following the transaction, the director now directly owns 3,046 shares of the company’s stock, valued at $1,819,893.62. The trade was a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. In related news, Director George J. Walsh III sold 400 shares of the firm’s stock in a transaction that occurred on Thursday, September 26th. The stock was sold at an average price of $597.47, for a total transaction of $238,988.00. Following the completion of the sale, the director now owns 3,046 shares of the company’s stock, valued at $1,819,893.62. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, EVP Nicholas Michael Westfall sold 1,713 shares of the firm’s stock in a transaction that occurred on Monday, September 9th. The stock was sold at an average price of $569.35, for a total value of $975,296.55. Following the sale, the executive vice president now directly owns 6,109 shares of the company’s stock, valued at $3,478,159.15. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 5,144 shares of company stock valued at $3,002,419 in the last ninety days. 3.32% of the stock is currently owned by insiders.

Chemed Company Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.